Narrow-Band UVB Therapy

On this page

NB-UVB Basics - The Healing Light

  • A specific type of phototherapy utilizing a narrow range of UVB light.
  • Mechanism: Primarily immunomodulatory; induces apoptosis of pathogenic T-lymphocytes, alters cytokine profiles (e.g., ↓IL-17, ↑IL-10).
  • Advantages: Greater efficacy and lower erythemogenic potential compared to broadband UVB.
  • Preferred for psoriasis, vitiligo, atopic dermatitis. UV light penetration into skin layers

⭐ NB-UVB primarily emits light in the 311-313 nm range, considered the most effective and safest part of the UVB spectrum for treating skin diseases.

NB-UVB Indications - Skin's Best Friend

  • Psoriasis: Chronic plaque, guttate (second-line).
  • Vitiligo: Generalized, especially facial/truncal.
  • Atopic Dermatitis: Moderate to severe, chronic.
  • Mycosis Fungoides: Early-stage (patch/plaque).
  • Polymorphic Light Eruption (PLE): Prophylaxis.
  • Chronic Urticaria: Symptomatic relief.
  • Lichen Planus: Generalized, pruritic.
  • Pruritus: Uremic, cholestatic, HIV-associated.

Patient receiving Narrow-Band UVB Therapy

⭐ For vitiligo, NB-UVB is often considered a first-line treatment, especially for generalized disease.

📌 Mnemonic: "People Value All Medical Professionals Carefully Listening Patiently" (Psoriasis, Vitiligo, Atopic dermatitis, Mycosis fungoides, PLE, Chronic urticaria, Lichen planus, Pruritus).

NB-UVB Cautions - Safety First Rays

  • Absolute Contraindications:
    • Lupus erythematosus
    • Dermatomyositis
    • History of skin cancer (melanoma, squamous cell carcinoma)
    • Genetic photosensitivity disorders (e.g., Xeroderma Pigmentosum)
    • Pemphigus / Pemphigoid (can be exacerbated)
    • Concurrent use of photosensitizing drugs (e.g., psoralens, retinoids, tetracyclines, thiazides) without specific protocols.
  • Relative Contraindications/Cautions:
    • History of multiple non-melanoma skin cancers
    • Severe photodamage
    • Cataracts or aphakia (unless eyes are protected)
    • Immunosuppression (e.g., post-transplant)
    • Children < 10 years (use with caution)
    • Pregnancy (generally considered safe, but discuss risks)

⭐ Patients with a history of melanoma or conditions like Xeroderma Pigmentosum are absolute contraindications for NB-UVB therapy.

⚠️ Always shield eyes, genitalia, and unaffected skin. Monitor for erythema, blistering, and long-term carcinogenesis risk. 📌 Skin Cancer Always Makes Phototherapy Scary (SCAMPS - Skin Cancer, Autoimmune, Medications, Photosensitivity, Severe damage).

NB-UVB Protocol - Dose & Delivery

  • Initial Dose:
    • Determined by Minimal Erythema Dose (MED) test (50-70% of MED).
    • Or, by skin phototype (e.g., Fitzpatrick I-II: ~0.2 J/cm²; III-IV: ~0.3 J/cm²).
  • Dose Escalation:
    • Gradual increase, typically 10-20% per treatment, if no adverse erythema.
    • Adjust based on skin reaction: maintain, decrease, or skip if significant redness.
  • Maximum Dose & Duration:
    • Individualized; aim for therapeutic effect without burns. Monitor cumulative exposure.

⭐ Treatment frequency is typically 2-3 times per week, with non-consecutive days to allow skin recovery.

NB-UVB Reactions - Sunburn's Cousins

  • Acute Reactions (Sunburn-like):
    • Erythema: Most common, dose-dependent. Mild cases resolve in 24 hrs.
    • Pruritus (itching): Common; manage with emollients, antihistamines.
    • Xerosis (dry skin): Frequent; emphasize regular moisturizer use.
    • Blistering: Rare, indicates significant overexposure; adjust dose.
    • Herpes simplex reactivation: Uncommon; consider prophylaxis if history.
  • Chronic Reactions:
    • Photoaging: Premature skin aging (wrinkles, lentigines) with long-term exposure.
    • Photocarcinogenesis: Theoretical NMSC risk. Higher with prior PUVA/immunosuppression. Regular skin surveillance vital.

⭐ The most common acute side effect of NB-UVB is asymptomatic erythema (mild sunburn), which usually resolves within 24 hours.

High‑Yield Points - ⚡ Biggest Takeaways

  • NB-UVB uses a peak wavelength of 311 nm (311-313 nm range).
  • Main action: immunomodulation via T-cell apoptosis and cytokine alteration.
  • Prime indications: psoriasis (widespread), vitiligo, atopic dermatitis, early mycosis fungoides.
  • Superior to BB-UVB: ↑ efficacy for psoriasis, ↓ erythema, ↓ cumulative dose.
  • Treatment protocol: 2-3 sessions/week; initial dose ~70% MED or fixed low dose.
  • Common acute effects: erythema, pruritus; chronic: photoaging, (lower) skin cancer risk.
  • Avoid in xeroderma pigmentosum, SLE, history of melanoma or multiple skin cancers.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Narrow-Band UVB Therapy

Test your understanding with these related questions

A nurse got accidental prick from the HIV infected needle. Which of the following statements is false regarding the management of this nurse?

1 of 5

Flashcards: Narrow-Band UVB Therapy

1/9

UVB has a _____ skin cancer risk than PUVA

TAP TO REVEAL ANSWER

UVB has a _____ skin cancer risk than PUVA

lesser::Lesser/Greater

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free